AnaCardio

AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

02Backed By1 investor

03Recent Activity

FROM Sound Bioventures

Existing investor in AnaCardio's EUR 62.5M Series B for heart failure therapy.

INVESTMENT·soundbioventures.com

SEP 30, 2026

04Similar Companies

D

RP

C

CP

TT

05Startup DNA

7

signals

Sectors
Business Model
Technology